Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIngenta Regulatory News (ING)

Share Price Information for Ingenta (ING)

Share Price is delayed by 15 minutes
Get Live Data
64.50    -20.00 (-23.67%)
Bid:
63.00
Ask:
66.00
Spread: 3.00 (4.762%)
Market Cap: £9.36m
ING Live PriceLast checked at - London Stock Exchange

Intraday Ingenta Share Chart

Interim Results

13 Sep 2017 07:00

RNS Number : 5649Q
Ingenta PLC
13 September 2017
Β 

13 September 2017

Β 

Ingenta plc

Β 

Interim Results

Β 

Β 

Ingenta plc (AIM: ING), ("Ingenta", the "Company" or the "Group") a leading provider of world-class software and services to the global publishing industry, today announces its unaudited interim results for the six months to 30 June 2017.

Β 

Financial Key Points

Β 

Β· Group revenues up 8% to Β£7.75m (2016: Β£7.18m)

Β· Adjusted EBITDA* up 116% to Β£659K (2016: Β£305K)

Β· Operating profit down 6% to Β£321K (2016: Β£341K)

Β· Cash at 30 June 2017: Β£1.3m (2016: Β£1.3m)

Β· Strong cash conversion and balances are stated after dividend payments and exceptional costs

Β 

Operational Key Points

Β 

Β· First Commercial Order to Cash (OTC) module went live in Q1

Β· Successful Content Management System (CMS) go live in Q1

Β· All software implementations remain on track

Β· Advertising customer base expanded into new territories

Β· Growth in digital capabilities and reach with new advertising partnership

Β· Sales team recruitment completed in Q2

Β· Good sales pipeline growth with promising opportunities in new market segments

Β 

Β 

*Earnings before Interest, Tax, Depreciation and Amortisation is calculated before foreign exchange differences and restructuring costs.

Β 

David Montgomery, Chief Executive of Ingenta plc, commented:

Β 

I'm pleased to announce that we have delivered another set of positive results which build on the progress made in 2016. There have been a number of operational highlights but perhaps the most significant was the speed and efficiency with which we integrated the 5 Fifteen business and then set about extending the sales pipeline and winning new customers. It is also encouraging to see that our plan to exploit new market segments is making real headway with discussions in place with a number of high profile customers. We have also been busy enhancing the product offering by signing a partnership which improves the digital capabilities of our product without the need for significant research and development spend.

Β 

Elsewhere, the Commercial OTC go live in Q1 now means we have a complete Commercial product set with referenceable clients. This, combined with a fully operational sales team, means we are in a strong position to exploit the product investment made in prior years.

Β 

As ever, these results would not have been possible without the dedication and professionalism of the Ingenta staff and I would like to thank everyone for their efforts and look forward to continued success in the second half of the year. The Board believes the Group is on track to meet market expectations for 2017.

Β 

Β 

For further information please contact:

Β 

Ingenta plc Tel: 01865 397 800

David Montgomery / Jon Sheffield

Β 

Cenkos Securities plc Tel: 0207 397 8900

Nicholas Wells / Elizabeth Bowman

Β 

Β 

Ingenta business

Β 

Revenue for the first half of 2017 has improved compared to the same period last year because of the inclusion of the advertising business which was acquired in the second half of 2016.

Β 

Kathryn Layland was appointed EVP of Business Development at the end of 2016 and during the first half of 2017 she has successfully restructured the sales and marketing team to enable it to generate sales growth across products, markets and territories. There is now a much stronger sales pipeline than in prior years and these efforts should be rewarded in the second half with a number of promising opportunities nearing completion.

Β 

A key sales success in 2017 was extending the advertising relationship with Hearst into the Italian market with further opportunities being actively explored to expand the product reach into new territories and market segments. The digital capabilities of the product have also been improved with the addition of a data management platform allowing users to gain valuable insights into their target audience.

Β 

The Commercial product reached a significant milestone by going live with the final 'OTC' module of its software offering. This installation is fully referenceable and now, with a much improved sales pipeline, it will provide added impetus to the sales and marketing efforts in this area.

Β 

On the content side, CMS too completed a successful go live in the first half and has 3 more scheduled for later in the year. The pipeline continues to be robust with a significant number of opportunities within the key scholarly and academic sphere.

Β 

Financial review

Β 

Revenues have improved because of the addition of the Advertising business that wasn't present in the first half of 2016. These advertising revenues yielded good margins and in combination with tight cost controls across the business, reported gross profit has improved.

Β 

Sales and marketing spend is marginally lower than last year due to restructuring and timing of new recruits this year. The sales team was at full strength by the end of the first half of 2017 and this signals the business has moved away from a heavy development stage and can concentrate on leveraging the product investment of prior years.

Β 

Administrative expenses have increased by Β£356K although the majority of this is due to exchange differences which are Β£271K worse than last year because of the relative movements in the Euro and Dollar rates. There has also been Β£42K of additional Goodwill amortisation charges relating to the acquired advertising business and an additional Β£61K of restructuring costs charged into 2017.

Β 

Profit from operations remained stable though results from the Chinese joint venture were down due to project delays. These are substantially complete at half year and a number of new projects are due to start in the second half of the year.

Β 

Cash Flow

Β 

Cash outflow from operations was Β£466K in the 6 months to 30 June 2017. The majority of this was due to timing of receipts with over Β£400K being received in early July. Significantly, the Company also paid out its maiden dividend of Β£169K in the first half of the year.

Β 

As in the prior year, the R&D tax credit of Β£143K (2016: Β£405K) was received in July and did not impact the first half cash flow.

Β 

Β 

Β 

Β 

Β 

D R Montgomery

Chief Executive Officer

Β 

Β 

Β 

Β 

Condensed Consolidated Interim Statement of Comprehensive Income

Β 

Β 

Β 

Unaudited

Six months ended

Unaudited

Six months ended

Β 

Β 

30 June 2017

30 June 2016

Β 

Note

Β£'000

Β£'000

Β 

Β 

Β 

Β 

Group revenue

Β 

7,747

7,175

Cost of sales

Β 

(4,860)

(4,614)

Gross profit

Β 

2,887

2,561

Β 

Β 

Β 

Β 

Sales and marketing expenses

Β 

(655)

(665)

Administrative expenses

Β 

(1,911)

(1,555)

Β 

Β 

Β 

Β 

Profit from operations

Β 

321

341

Β 

Β 

Β 

Β 

Share of (loss) / profit from equity accounted investment

4

(150)

40

Β 

Β 

Β 

Β 

Finance costs

Β 

(20)

(13)

Β 

Β 

Β 

Β 

Profit before tax

Β 

151

368

Β 

Β 

Β 

Β 

Tax

Β 

(5)

(2)

Β 

Β 

Β 

Β 

Retained profit for the period

Β 

146

366

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Other comprehensive expenses which will be reclassified subsequently to profit or loss:

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Exchange differences on translating foreign operations

Β 

(46)

(27)

Β 

Β 

Β 

Β 

Total comprehensive income for the period

Β 

100

339

Β 

Β 

Β 

Β 

Basic profit per share - pence

5

0.59p

Β 

2.08p

Diluted profit per share - pence

5

0.58p

2.01p

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Analysis of profit from operations

Β 

Β 

Β 

Profit before net finance costs, tax, depreciation and foreign exchange gains and losses (EBITDA)

Β 

659

305

Depreciation

Β 

(132)

(90)

Foreign exchange (loss) / gain

Β 

(94)

177

Restructuring costs

Β 

(112)

(51)

Profit from operations

Β 

321

341

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Condensed Consolidated Interim Statement of Financial Position

Β 

Β 

Β 

Unaudited

30 June 2017

Unaudited

30 June 2016

Β 

Note

Β£'000

Β£'000

Non-current assets

Β 

Β 

Β 

Goodwill

3

4,900

3,737

Other intangible assets

3

408

-

Property, plant & equipment

Β 

172

213

Investments accounted for using the equity method

4

218

238

Β 

Β 

5,698

4,188

Current assets

Β 

Β 

Β 

Trade and other receivables

6

3,790

3,306

Research and development tax credit receivable

Β 

143

405

Cash and cash equivalents

7

1,255

1,293

Β 

Β 

5,188

5,004

Β 

Β 

Β 

Β 

Total assets

Β 

10,886

9,192

Β 

Β 

Β 

Β 

Equity

Β 

Β 

Β 

Share capital

Β 

1,692

1,632

Share premium

Β 

8,999

8,294

Merger reserve

Β 

11,055

11,055

Reverse acquisition reserve

Β 

(5,228)

(5,228)

Translation reserve

Β 

(917)

(914)

Investment in own shares

Β 

-

(1)

Share option reserve

Β 

80

19

Retained earnings

Β 

(10,263)

(10,873)

Β 

Β 

5,418

3,984

Non-current liabilities

Β 

Β 

Β 

Deferred tax liability

Β 

82

-

Finance leases

Β 

21

69

Β 

Β 

103

69

Current liabilities

Β 

Β 

Β 

Trade and other payables

8

3,538

2,874

Deferred income

Β 

1,827

2,265

Β 

Β 

5,365

5,139

Β 

Β 

Β 

Β 

Total equity and liabilities

Β 

10,886

9,192

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Unaudited condensed consolidated interim statement of changes in equity

Β 

Β 

Share capital

Share premium

Merger reserve

Reverse acquisition reserve

Translation reserve

Investment in own shares

Share option reserve

Retained Earnings

Total

Β 

Β£'000

Β£'000

Β£'000

Β£'000

Β£'000

Β£'000

Β£'000

Β£'000

Β£'000

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Balance at 1 January 2017

1,692

8,999

11,055

(5,228)

(871)

-

-

(10,240)

5,407

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Dividends paid

-

-

-

-

-

-

-

(169)

(169)

Share based payment expense

-

-

-

-

-

-

80

-

80

Transactions with owners

-

-

-

-

-

-

80

(169)

(89)

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Profit for the period

-

-

-

-

-

-

-

146

146

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Other comprehensive income:

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Exchange differences on translation of foreign operations

-

-

-

-

(46)

-

-

-

(46)

Total comprehensive income / (expense) for the period

-

-

-

-

(46)

-

-

146

100

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Balance at 30 June 2017

1,692

8,999

11,055

(5,228)

(917)

-

80

(10,263)

5,418

Β 

Β 

Β 

Β 

Β 

Share capital

Share premium

Merger reserve

Reverse acquisition reserve

Translation reserve

Investment in own shares

Share option reserve

Retained Earnings

Total

Β 

Β£'000

Β£'000

Β£'000

Β£'000

Β£'000

Β£'000

Β£'000

Β£'000

Β£'000

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Balance at 1 January 2016

1,632

8,294

11,055

(5,228)

(887)

(1)

-

(11,239)

3,626

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Share based payment expense

-

-

-

-

-

-

19

-

19

Transactions with owners

-

-

-

-

-

-

19

-

19

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Profit for the period

-

-

-

-

-

-

-

366

366

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Other comprehensive income:

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Exchange differences on translation of foreign operations

-

-

-

-

(27)

-

-

-

(27)

Total comprehensive income / (expense) for the period

-

-

-

-

(27)

-

19

366

358

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Balance at 30 June 2016

1,632

8,294

11,055

(5,228)

(914)

(1)

19

(10,873)

3,984

Β 

Β 

Β 

Β 

Β 

Β 

Condensed Consolidated Interim Statement of Cash Flows

Β 

Β 

Β 

Unaudited

Six months ended

Unaudited

Six months ended

Β 

Β 

30 June 2017

Β 

30 June 2016

Β 

Β 

Note

Β£'000

Β£'000

Β 

Β 

Β 

Β 

Profit before tax

Β 

151

368

Β 

Β 

Β 

Β 

Adjustments for:

Β 

Β 

Β 

Share of loss / (profit) from equity accounted investment

4

150

(40)

Depreciation

Β 

132

90

Share based payment expense

Β 

80

19

Interest expense

Β 

20

13

Unrealised foreign exchange differences

Β 

(46)

(27)

Decrease in trade and other receivables

Β 

1,600

961

Decrease in trade and other payables

Β 

(2,553)

(2,056)

Β 

Β 

Β 

Β 

Cash outflow from operations

Β 

(466)

(672)

Β 

Β 

Β 

Β 

Tax Paid

Β 

(5)

(2)

Net cash outflow from operating activities

Β 

(471)

(674)

Β 

Β 

Β 

Β 

Cash flows from financing activities

Β 

Β 

Β 

Share issue

Β 

-

-

Dividends paid

Β 

(169)

-

Payment of finance leases

Β 

(61)

(90)

Loans received

Β 

-

-

Loans repaid

Β 

-

-

Interest paid

Β 

(20)

(13)

Net cash used in financing activities

Β 

(250)

(103)

Β 

Β 

Β 

Β 

Cash flows from investing activities

Β 

Β 

Β 

Purchase of property, plant and equipment

Β 

(52)

(7)

Net cash used in investing activities

Β 

(52)

(7)

Β 

Β 

Β 

Β 

Net decrease in cash and cash equivalents

Β 

(773)

(784)

Β 

Β 

Β 

Β 

Cash and cash equivalents at beginning of period

Β 

2,028

2,077

Β 

Β 

Β 

Β 

Cash & cash equivalents at end of period

7

1,255

1,293

Β 

Β 

Β 

Β 

Notes to the Unaudited Interim Report for the six months ended 30 June 2017

1. Nature of operations and general informationΒ 

Ingenta plc (the "Company") and its subsidiaries (together 'the Group') is a provider of technology and supporting services to content providers and publishers. The nature of the Group's operations and its principal activities are set out in the full annual financial statements.

Β 

The Company is incorporated in the United Kingdom under the Companies Act 2006. The Company's registration number is 837205 and its registered office is 8100 Alec Issigonis Way, Oxford OX4 2HU. The condensed consolidated interim financial statements were authorised for issue by the Board of Directors on 13 September 2017.

Β 

The financial information set out in this interim report does not constitute statutory accounts as defined in section 404 of the Companies Act 2006. The Group's statutory financial statements for the year ended 31 December 2016, prepared under IFRS as adopted by the European Union, have been filed with the Registrar of Companies. The auditor's report on those financial statements was unqualified and did not contain a statement under section 498 (2) or section 498 (3) of the Companies Act 2006.

2. Basis of preparationΒ 

These unaudited condensed consolidated interim financial statements are for the six months ended 30 June 2017. They have been prepared following the recognition and measurement principles of IFRS as adopted by the European Union. They do not include all of the information required for full annual financial statements, and should be read in conjunction with the consolidated financial statements of the Group for the year ended 31 December 2016.

Β 

These condensed consolidated interim financial statements have been prepared on the going concern basis under the historical cost convention and have been prepared in accordance with the accounting policies adopted in the last annual financial statements for the year ended 31 December 2016.

Β 

The accounting policies have been applied consistently throughout the Group for the purposes of preparation of these consolidated interim financial statements.

Β 

A detailed set of accounting policies can be found in the annual accounts available on our website, www.ingenta.com or by writing to the Company Secretary at the registered office as above.

3. Goodwill and IntangiblesΒ 

Full details of the Group's policies on Goodwill and Intangibles is presented in the financial statements for the year ended 31 December 2016.

Β 

Β 

Β 

4. Equity accounted investment

Β 

The Group holds a 49% voting and equity interest in Beijing Ingenta Digital Publishing Technology Ltd (BIDPT), a joint venture company registered in the People's Republic of China.

Β 

This investment is accounted for under the equity method. BIDPT has a reporting date of 31 December. The shares are not publicly listed on a stock exchange and hence published price quotes are not available. Certain unaudited financial information on BIDPT is as follows:

Β 

Β 

30 June 2017

30 June 2016

Β 

Β£'000

Β£'000

Β 

Β 

Β 

Assets

2,030

1,522

Liabilities

1,479

958

Β 

Β 

Β 

Β 

Six months ended

Six months ended

Β 

30 June 2017

30 June 2016

Β 

Β£'000

Β£'000

Β 

Β 

Β 

Revenues

451

812

(Loss) / Profit

(306)

81

(Loss) / Profit attributable to the Group

(150)

40

Β 

Β 

Β 

Changes in equity accounted investment

Β 

Six months ended

30 June 2017

Six months ended

30 June 2016

Β 

Β£'000

Β£'000

Β 

Β 

Β 

Β 

Β 

Investment Book Value as at 1 January

368

198

Β 

(Loss) / Profit attributable to the Group

(150)

40

Β 

Β 

Β 

Β 

Β 

Investment Book Value as at 30 June

218

238

Β 

Β 

Β 

Β 

Β 

Β 

Dividends are subject to the approval of at least 51% of all shareholders of BIDPT. The Group has received no dividends.

Β 

Β 

Β 

Β 

5. Profit / (loss) per share

Β 

Basic profit / (loss) per share is calculated by dividing the profit / (loss) attributable to ordinary shareholders by the weighted average number of ordinary shares outstanding during the period.

Β 

For diluted profit / (loss) per share, the weighted average number of ordinary shares in issue is adjusted to assume conversion of all dilutive potential ordinary shares.

Β 

Β 

Β 

Six months ended

Six months ended

Β 

30 June 2017

30 June 2016

Β 

Β 

Β 

Attributable profit (Β£'000)

100

339

Β 

Β 

Β 

Weighted average number of ordinary basic shares (basic)

Β 

16,919,609

Β 

16,319,609

Β 

Β 

Β 

Weighted average number of ordinary shares (diluted)

17,375,609

16,845,609

Β 

Β 

Β 

Profit per share (basic) arising from both total and continuing operations

0.59p

2.08p

Β 

Β 

Β 

Profit per share (dilutive) arising from both total and continuing operations

0.58p

2.01p

Β 

Β 

6. Trade and other receivables

Β 

Trade and other receivables comprise the following:

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

30 June 2017

Β 

30 June 2016

Β 

Β 

Β£'000

Β 

Β£'000

Β 

Β 

Β 

Β 

Β 

Trade receivables - gross

Β 

2,712

Β 

2,322

Less: provision for impairment of trade receivables

Β 

(12)

Β 

(21)

Trade receivables - net

Β 

2,700

Β 

2,301

Other receivables

Β 

117

Β 

124

Prepayments and accrued income

Β 

973

Β 

881

Β 

Β 

3,790

Β 

3,306

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

7. Cash and cash equivalents

Β 

Β 

Β 

30 June 2017

Β 

30 June 2016

Β 

Β 

Β£'000

Β 

Β£'000

Β 

Β 

Β 

Β 

Β 

Cash and cash equivalents

Β 

1,255

Β 

6,528

Bank overdraft

Β 

-

Β 

(5,235)

Cash and cash equivalents including overdraft

Β 

1,255

Β 

1,293

Β 

Β 

Β 

Β 

Β 

Β 

Β 

8. Trade and other payables

Β 

Trade payables comprise the following:

Β 

Β 

Β 

Β 

30 June 2017

Β 

30 June 2016

Β 

Β 

Β£'000

Β 

Β£'000

Β 

Β 

Β 

Β 

Β 

Trade payables

Β 

423

Β 

589

Social security and other taxes

Β 

396

Β 

293

Other payables

Β 

1,083

Β 

1,196

Accruals

Β 

1,636

Β 

796

Β 

Β 

Β 

Β 

Β 

Β 

Β 

3,538

Β 

2,874

Β 

Β 

Β 

Β 

Β 

Β 

9. Contingencies and commitments

Β 

There were no contingencies and commitments at the end of this or the comparative period.

10. Post balance sheet events

Β 

There were no material events subsequent to the end of the interim reporting period that have not been reflected in the interim financial statements.

11. Copies of the Interim Financial Statements

Β 

A copy of the interim statement is available on the Company's website, www.ingenta.com, and from the Company's registered office, 8100 Alec Issigonis Way, Oxford OX4 2HU.

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
IR BRGDCUSBBGRD
Date   Source Headline
22nd Nov 20169:40 amRNSDirector/PDMR Shareholding
2nd Nov 20167:00 amRNSDirectorate Change
9th Aug 201611:12 amRNSDirectorate Update
1st Aug 20164:53 pmRNSDirectorate Change - Replacement
1st Aug 20167:00 amRNSDirectorate Change
29th Jul 201611:02 amRNSDirector/PDMR Shareholding
29th Jul 20167:00 amRNSInterim Results
29th Jul 20167:00 amRNSAcquisition and Subscription
22nd Jun 20167:00 amRNSHolding(s) in Company
11th May 201612:33 pmRNSFurther re. Change of Name
10th May 20164:19 pmRNSHolding(s) in Company
10th May 201611:48 amRNSResult of AGM
5th Apr 201611:15 amRNSNotice of AGM
31st Mar 20167:00 amRNSFinal Results
1st Feb 20163:53 pmRNSGrant of Options and Director Shareholding
29th Jan 201610:58 amRNSYear End Trading Update
26th Jan 20164:32 pmRNSHolding(s) in Company
17th Dec 20157:00 amRNSDirectorate Change
27th Oct 20154:54 pmRNSHolding(s) in Company
15th Oct 20157:00 amRNSDirectorate Change
22nd Sep 20154:40 pmRNSTrading Statement
5th Aug 20159:46 amRNSHolding(s) in Company
4th Aug 20158:37 amRNSHolding(s) in Company
27th Jul 20152:59 pmRNSDirector/PDMR Shareholding
23rd Jul 20154:25 pmRNSHolding(s) in Company
23rd Jul 20157:00 amRNSInterim Results
16th Jul 201512:51 pmRNSHolding(s) in Company
30th Jun 201510:50 amRNSHolding(s) in Company
25th Jun 20152:42 pmRNSHolding(s) in Company
24th Jun 20152:57 pmRNSDirector/PDMR Shareholding
24th Jun 20159:26 amRNSHolding(s) in Company
19th Jun 201512:35 pmRNSHolding(s) in Company
17th Jun 20153:59 pmRNSResult of AGM and Trading Update
17th Jun 20153:57 pmRNSDirectorate Change
17th Jun 20159:31 amRNSHolding(s) in Company
16th Jun 20154:42 pmRNSHolding(s) in Company
16th Jun 201512:52 pmRNSCompletion of fundraising & directors' interests
12th Jun 201510:59 amRNSResult of General Meeting & Offer
26th May 20152:26 pmRNSPlacing and Offer
26th May 20157:03 amRNSPlacing and Offer
26th May 20157:01 amRNSAppointment of Nomad and Broker
26th May 20157:01 amRNSFinal Results
20th May 20157:00 amRNSUpdate Statement
16th Apr 20155:31 pmRNSHolding(s) in Company
21st Jan 20157:00 amRNSTrading Statement
18th Dec 20147:00 amRNSPublishing Technology expands client base in 2014
25th Nov 20147:00 amRNSDirectors' Loans
24th Nov 20141:52 pmRNSHolding(s) in Company
19th Nov 201410:10 amRNSHolding(s) in Company
5th Nov 20147:00 amRNSAppointment of Chief Technology Officer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.